Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Time to Progression”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01217034
What this trial is testing

Transcatheter Arterial Chemoembolization Therapy In Combination With Sorafenib

Who this might be right for
Hepatocellular CarcinomaUnresectable Hepatocellular CarcinomaCarcinoma, Hepatocellular+1 more
Kindai University 228
Large-scale testing (Phase 3)Study completedNCT02980731
What this trial is testing

A Study Evaluating the Impact of Venetoclax on the Quality of Life for Subjects With Relapsed (Your Cancer Has Come Back) or Refractory (no Response to Previous Cancer Treatments) Chronic Lymphocytic Leukemia (CLL) While Receiving Venetoclax Monotherapy (a Single Agent).

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)
AbbVie 210
Post-approval studies (Phase 4)UnknownNCT02525380
What this trial is testing

Safety and Efficacy of Doxorubicin-eluting-bead Embolization in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Seoul National University Hospital 30
Not applicableStudy completedNCT04768894
What this trial is testing

Impact of Time to Re-staging Transurethral Resection on Recurrence and Progression Rates

Who this might be right for
Bladder Cancer
Saglik Bilimleri Universitesi 109
Large-scale testing (Phase 3)Study completedNCT05459532
What this trial is testing

A Randomised, Multi-centre, Double-blind, Phase 3 Study to Observe the Effectiveness, Safety and Tolerability of Molnupiravir Compared to Placebo Administered Orally to High-risk Adult Outpatients With Mild COVID-19 Receiving Local Standard of Care in South Africa

Who this might be right for
COVID-19
University of Witwatersrand, South Africa 59
Testing effectiveness (Phase 2)WithdrawnNCT02705339
What this trial is testing

Rociletinib Genomic Landscape in Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell LungNon-Small Cell Lung CancerNonsmall Cell Lung Cancer
Washington University School of Medicine
Testing effectiveness (Phase 2)WithdrawnNCT00916669
What this trial is testing

Study to Evaluate the Effect of Two Different Doses of Enoxaparin Sodium in Combination With Standard Chemotherapy in Patients With Stage Small Cell Lung Cancer (SCLC)

Who this might be right for
Small Cell Lung Cancer
Massachusetts General Hospital
Not applicableStudy completedNCT06077851
What this trial is testing

Continuous Monitoring of Vital Signs at Home (WARD HOME II)

Who this might be right for
Vital Sign MonitoringClinical DeteriorationHospital At Home
Bispebjerg Hospital 83
Not applicableLooking for participantsNCT07464470
What this trial is testing

Comparison of Molecular-Genetic Concordance of the Primary Tumor and Brain Metastases of Gastroesophageal Cancers

Who this might be right for
Gastric CancerEsophageal CancerBrain Metastases
Blokhin's Russian Cancer Research Center 30
Not applicableEnded earlyNCT02431169
What this trial is testing

Genomic Landscape of EGFR Mutant NSCLC Prior to Erlotinib and at the Time of Disease Progression

Who this might be right for
Carcinoma, Non-Small-Cell-LungNon-Small Cell Lung CancerNonsmall Cell Lung Cancer
Washington University School of Medicine 5
Testing effectiveness (Phase 2)Study completedNCT01392183
What this trial is testing

Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC)

Who this might be right for
Kidney Cancer
M.D. Anderson Cancer Center 69
Testing effectiveness (Phase 2)Study completedNCT02006667
What this trial is testing

Herceptin (Trastuzumab) Combination Therapy in Patients With Metastatic Urothelial Cancer

Who this might be right for
Urinary Tract Cancer
Hoffmann-La Roche 13
Not applicableStudy completedNCT06996301
What this trial is testing

Clinical Utility of a PCR Compared to Culture and Sensitivity Testing for the Management of cUTI in Adults.

Who this might be right for
Urinary Tract Infection ComplicatedUrinary Tract Infection (cUTI)Urinary Tract Infection (Diagnosis)
Doc Lab Inc 773
Testing effectiveness (Phase 2)Ended earlyNCT00595985
What this trial is testing

Sorafenib as a Second Line Treatment in Patients With Advanced or Metastatic Gastric Cancer

Who this might be right for
Gastric Cancer
Fudan University 5
Not applicableLooking for participantsNCT04805255
What this trial is testing

A Neurocognitive Study in Patients With Brain Oligometastases Receiving Hypofractionated SRT

Who this might be right for
Brain Metastases, Adult
Chang Gung Memorial Hospital 135
Not applicableStudy completedNCT00292552
What this trial is testing

Evaluation of COPD (Chronic Obstructive Pulmonary Disease) to Longitudinally Identify Predictive Surrogate Endpoints

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 2,747
Testing effectiveness (Phase 2)Study completedNCT00076102
What this trial is testing

Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis 1Neurofibroma, Plexiform
National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)UnknownNCT00892827
What this trial is testing

Combined Treatment With Fresh Frozen Plasma and Rituximab (Mabthera) in Patients With Advanced Refractory Chronic Lymphocytic Leukemia

Who this might be right for
Advanced Refractory Chronic Lymphocytic Leukemia
Wolfson Medical Center 10
Testing effectiveness (Phase 2)UnknownNCT01192243
What this trial is testing

Study of Gefitinib Compared With Pemetrexed/Cisplatin in Advanced Non-Small Cell Lung Cancer Patients

Who this might be right for
ToxicityNon-small Cell Lung Cancer
Fudan University 68
Testing effectiveness (Phase 2)Ended earlyNCT01610570
What this trial is testing

Mithramycin for Children and Adults With Solid Tumors or Ewing Sarcoma

Who this might be right for
Ewing SarcomaSarcoma
National Cancer Institute (NCI) 8
Next Page